Table 2.
Chorioretinopathy staging at first and last documented exams for each subject demonstrate progression of disease with time.
| Age (Years) | logMAR (OD/OS) | Sph Eq. in Diopters (OD/OS) | Chorioretinopathy Staging (OD/OS) | Age (Years) | logMAR (OD/OS) | Sph Eq. in Diopters (OD/OS) | Chorioretinopathy Staging (OD/OS) | |
|---|---|---|---|---|---|---|---|---|
| LCHADD | ||||||||
|
| ||||||||
| LC01 | 6.7 | 0.54/0.3 | −2.75/−2.38 | 2/2 | 12.5 | 0.3/0.3 | −6.25/−4.50 | 3/3 |
| LC02 | 3.2 | CSM/CSM | −1.00/−1.00 | 2/2 | 6.8 | 0.8/1.0 | −4.75/−4.88 | 4/4 |
| LC03 | 0.8 | CSM/CSM | +2.25/+2.25 | 1*/1* | 5.8 | 0.5/0.3 | +0.25/+0.63 | 2/2 |
| LC04 | 5.3 | 0.1/0.1 | −0.63/−0.63 | 2/2* | 14.3 | 1.3/0.3 | −5.50/−5.50 | 4*/4* |
| LC05 | 9.5 | 0.3/0.1 | −1.63/−1.00 | 3/3 | 15.8 | 0.3/0.4 | −9.50/−8.88 | 3/*3* |
| LC06 | 5.2 | 0.0/0.0 | +1.00/+1.00 | 2/2 | 7.6 | 0.1/0.1 | +0.63/+0.50 | 2/2 |
| LC07 | 4.0 | 0.2/0.3 | −1.50/−1.50 | 2/2 | 6.4 | 0.2/0.1 | −2.00/−2.00 | 3/3 |
| LC08 | 8.3 | 0.4/0.4 | −0.50/−0.50 | 3/3 | 12.7 | 0.2/1.0 | −8.00/−7.75 | 4/4 |
| LC09 | 11.1 | −0.1/−0.1 | +1.12/+1.94 | 3/2 | 14.6 | 0.0/0.1 | −1.88/−0.88 | 3/3 |
| LC10 | 17.7 | 0.9/0.0 | −5.13/−5.25 | 4+*/4+* | 18.0 | 1.0/0.0 | −5.13/−5.25 | 4+*/4+* |
| LC11 | 0.8 | CSM/CSM | +1.50/+0.75 | 2*/2* | 2.9 | CSM/CSM | +1.25/+1.25 | 2/2 |
| LC12 | 1.4 | CSM/CSM | −0.50/−0.50 | 2*/2* | 5.3 | 0.0/0.0 | −0.75/−1.00 | 2/2 |
| LC13 | 7.3 | 0.6/0.1 | 0.00/+1.13 | 2/2 | 9.8 | 1.0/0.7 | −0.63/0.00 | 3*/3* |
| LC14 | 4.8 | 0.3/0.3 | -- | 2/2 | 24.2 | 1.3/0.1 | −3.75/−4.25 | 4+/4 |
| LC15 | 0.4 | CSM/CSM | −0.88/−0.88 | --/-- | 11.3 | 0.3/0.4 | -- | --/-- |
| LC25 | 11.8 | 0.2/1.5 | −3.23/−4.13 | 4+*/4* | 14.2 | 0.4/1.4 | −3.25/−4.25 | 4+/4 |
| LC27 | 1.6 | CSM/CSM | -- | --/-- | 9.2 | −0.1/0.0 | −0.38/−0.13 | 2*/2* |
| LC31 | 1.4 | CSM/CSM | +2.50/+2.50 | 1*/1* | 5.4 | 0.0/0.0 | +0.88/+1.00 | 1*/1* |
|
| ||||||||
| TFPD | ||||||||
|
| ||||||||
| LC16 | 10.3 | 0.1/0.1 | +0.93/+1.07 | 1/1 | 14.4 | 0.0/−0.1 | 0.00/0.00 | 2/2 |
| LC17 | 4.7 | 0.0/0.0 | +0.63/+0.68 | 1/1 | 8.7 | 0.0/0.0 | +0.38/+0.38 | 1/1 |
| LC18 | 1.0 | CSM/CSM | +0.75/+1.00 | 2/2 | 3.0 | CSM/CSM | +0.25/+0.25 | 2/2 |
Exam descriptions and fundus photos were used to stage the chorioretinopathy using the fundus staging criteria developed by Tyni et al.12 The asterisk denotes visits when no fundus photo was available; in these cases, grading was based solely on clinical data. The stage “4+” is not included within Tyni et al. staging criteria, but included to designate times when foveal scarring was appreciated on exam. Corresponding ages, visual acuity (logMAR), spherical equivalent (Sph. Eq.) were included for visits if available. Subject LC15 did not have fundus photos or exam descriptions available to stage. “—“ = unavailable data; “CSM”= central, steady, and maintained.